pharma hires

R&D

In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.

R&D

Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.

R&D

April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.

R&D

A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.

R&D

The pharmaceutical and biotech sectors have seen a flurry of executive movement this month.

R&D

The new year brought a slew of new faces in the pharma and biotech world, especially in the top jobs, with a number of CEO changes at biotech firms.